| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 9.59e-11 | 5 | 200 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 5.71e-10 | 6 | 200 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 3.83e-07 | 16 | 200 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | calcium ion binding | CLSTN2 HRNR MELK ITPR1 ITPR2 HMCN2 JAG1 USP32 AMY1A AMY1B AMY1C AMY2A AMY2B FAT3 CPS1 EYS HMCN1 PRKCSH CDH4 | 1.99e-04 | 749 | 200 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 2.97e-04 | 3 | 200 | 2 | GO:0005220 | |
| Domain | Alpha_amylase | 1.23e-08 | 4 | 198 | 4 | IPR006046 | |
| Domain | Aamy_C | 1.23e-08 | 4 | 198 | 4 | SM00632 | |
| Domain | Alpha-amylase_C | 6.08e-08 | 5 | 198 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 6.08e-08 | 5 | 198 | 4 | IPR006048 | |
| Domain | Glyco_hydro_13_cat_dom | 4.18e-07 | 7 | 198 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 4.18e-07 | 7 | 198 | 4 | PF00128 | |
| Domain | Aamy | 4.18e-07 | 7 | 198 | 4 | SM00642 | |
| Domain | A-amylase_C | 1.17e-06 | 3 | 198 | 3 | IPR031319 | |
| Domain | Glyco_hydro_b | 1.53e-05 | 15 | 198 | 4 | IPR013780 | |
| Domain | Glyco_hydro_13 | 2.29e-05 | 6 | 198 | 3 | IPR015902 | |
| Domain | Ig_I-set | 3.64e-05 | 190 | 198 | 10 | IPR013098 | |
| Domain | I-set | 3.64e-05 | 190 | 198 | 10 | PF07679 | |
| Domain | IGc2 | NFASC HMCN2 PXDNL KIT VCAM1 FLT1 DSCAM ADAMTSL3 HMCN1 CEACAM16 LSAMP | 4.36e-05 | 235 | 198 | 11 | SM00408 |
| Domain | Ig_sub2 | NFASC HMCN2 PXDNL KIT VCAM1 FLT1 DSCAM ADAMTSL3 HMCN1 CEACAM16 LSAMP | 4.36e-05 | 235 | 198 | 11 | IPR003598 |
| Domain | Ricin_B_lectin | 1.30e-04 | 25 | 198 | 4 | PF00652 | |
| Domain | RICIN | 2.06e-04 | 28 | 198 | 4 | SM00458 | |
| Domain | RICIN_B_LECTIN | 2.06e-04 | 28 | 198 | 4 | PS50231 | |
| Domain | Ricin_B_lectin | 2.71e-04 | 30 | 198 | 4 | IPR000772 | |
| Domain | DUF2075 | 3.33e-04 | 3 | 198 | 2 | PF09848 | |
| Domain | InsP3_rcpt-bd | 3.33e-04 | 3 | 198 | 2 | IPR000493 | |
| Domain | DUF2075 | 3.33e-04 | 3 | 198 | 2 | IPR018647 | |
| Domain | - | 3.92e-04 | 14 | 198 | 3 | 2.60.40.1180 | |
| Domain | IG | AXL NFASC HMCN2 PXDNL NCR1 KIT VCAM1 FLT1 DSCAM ADAMTSL3 HMCN1 CEACAM16 LSAMP | 5.76e-04 | 421 | 198 | 13 | SM00409 |
| Domain | Ig_sub | AXL NFASC HMCN2 PXDNL NCR1 KIT VCAM1 FLT1 DSCAM ADAMTSL3 HMCN1 CEACAM16 LSAMP | 5.76e-04 | 421 | 198 | 13 | IPR003599 |
| Domain | G2F | 6.62e-04 | 4 | 198 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 6.62e-04 | 4 | 198 | 2 | PS50993 | |
| Domain | GFP | 6.62e-04 | 4 | 198 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 6.62e-04 | 4 | 198 | 2 | IPR006605 | |
| Domain | Glyco_hydro_catalytic_dom | 6.82e-04 | 38 | 198 | 4 | IPR013781 | |
| Domain | IG_LIKE | AXL NFASC HMCN2 PXDNL NCR1 KIT VCAM1 FLT1 DSCAM ADAMTSL3 HMCN1 CD28 CEACAM16 LSAMP | 7.79e-04 | 491 | 198 | 14 | PS50835 |
| Domain | ig | 9.72e-04 | 190 | 198 | 8 | PF00047 | |
| Domain | Immunoglobulin | 9.72e-04 | 190 | 198 | 8 | IPR013151 | |
| Domain | Ig-like_dom | AXL NFASC HMCN2 PXDNL NCR1 KIT VCAM1 FLT1 DSCAM ADAMTSL3 HMCN1 CD28 CEACAM16 LSAMP | 9.83e-04 | 503 | 198 | 14 | IPR007110 |
| Domain | Apc4_WD40_dom | 1.17e-03 | 20 | 198 | 3 | IPR024977 | |
| Domain | ANAPC4_WD40 | 1.17e-03 | 20 | 198 | 3 | PF12894 | |
| Domain | IGv | 1.20e-03 | 75 | 198 | 5 | SM00406 | |
| Domain | Adcy_conserved_dom | 1.63e-03 | 6 | 198 | 2 | IPR009398 | |
| Domain | RIH_assoc-dom | 1.63e-03 | 6 | 198 | 2 | IPR013662 | |
| Domain | Pectin_lyas_fold | 1.63e-03 | 6 | 198 | 2 | IPR012334 | |
| Domain | PbH1 | 1.63e-03 | 6 | 198 | 2 | SM00710 | |
| Domain | - | 1.63e-03 | 6 | 198 | 2 | 2.160.20.10 | |
| Domain | DUF1053 | 1.63e-03 | 6 | 198 | 2 | PF06327 | |
| Domain | Ins145_P3_rec | 1.63e-03 | 6 | 198 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.63e-03 | 6 | 198 | 2 | PF08454 | |
| Domain | RIH_dom | 1.63e-03 | 6 | 198 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.63e-03 | 6 | 198 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.63e-03 | 6 | 198 | 2 | IPR015925 | |
| Domain | - | 1.63e-03 | 6 | 198 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.63e-03 | 6 | 198 | 2 | PF01365 | |
| Domain | PbH1 | 1.63e-03 | 6 | 198 | 2 | IPR006626 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 1.61e-08 | 9 | 151 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 5.79e-08 | 11 | 151 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 3.80e-06 | 23 | 151 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 1.06e-05 | 28 | 151 | 5 | M27837 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 3.81e-05 | 36 | 151 | 5 | M39831 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 6.49e-05 | 8 | 151 | 3 | MM14717 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | MKRN4P MKRN1 PSMD2 PSMD5 ADCY5 PIK3R1 PHLPP1 FGF9 KIT ADCY4 CD28 | 8.49e-05 | 252 | 151 | 11 | MM15585 |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | MKRN1 PSMD2 PSMD5 ADCY5 ITPR1 ITPR2 PIK3R1 PHLPP1 FGF9 KIT ADCY4 CD28 | 1.39e-04 | 313 | 151 | 12 | M27867 |
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 3.76e-11 | 6 | 202 | 5 | 2788608 | |
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 3.76e-11 | 6 | 202 | 5 | 6608795 | |
| Pubmed | 3.76e-11 | 6 | 202 | 5 | 2452973 | ||
| Pubmed | 3.76e-11 | 6 | 202 | 5 | 15286789 | ||
| Pubmed | 3.76e-11 | 6 | 202 | 5 | 2081604 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 3.47e-10 | 8 | 202 | 5 | 6200103 | |
| Pubmed | 3.47e-10 | 8 | 202 | 5 | 12414807 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 3.47e-10 | 8 | 202 | 5 | 7523515 | |
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 1.10e-09 | 4 | 202 | 4 | 26132294 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 1.10e-09 | 4 | 202 | 4 | 6166922 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 1.10e-09 | 4 | 202 | 4 | 4745489 | |
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 3872721 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 1.10e-09 | 4 | 202 | 4 | 6162570 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 1.10e-09 | 4 | 202 | 4 | 2987507 | |
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 6091898 | ||
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 1.10e-09 | 4 | 202 | 4 | 6162108 | |
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 1.10e-09 | 4 | 202 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 1.10e-09 | 4 | 202 | 4 | 2989529 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 1.10e-09 | 4 | 202 | 4 | 6207174 | |
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 2410924 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 1.10e-09 | 4 | 202 | 4 | 2332419 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 1.10e-09 | 4 | 202 | 4 | 6165618 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 1.10e-09 | 4 | 202 | 4 | 26098870 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 1.10e-09 | 4 | 202 | 4 | 94264 | |
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 2476716 | ||
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 1.10e-09 | 4 | 202 | 4 | 6163812 | |
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 16152770 | ||
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 2423416 | ||
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 6161122 | ||
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 1.10e-09 | 4 | 202 | 4 | 1141004 | |
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 1.10e-09 | 4 | 202 | 4 | 2431276 | |
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 2.82e-09 | 11 | 202 | 5 | 7493641 | |
| Pubmed | 5.50e-09 | 5 | 202 | 4 | 6529441 | ||
| Pubmed | 5.50e-09 | 5 | 202 | 4 | 6176569 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 5.50e-09 | 5 | 202 | 4 | 34276419 | |
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 5.50e-09 | 5 | 202 | 4 | 8661735 | |
| Pubmed | 5.50e-09 | 5 | 202 | 4 | 1348427 | ||
| Pubmed | EPHB4 SETX RPN2 PSMD2 GALNT7 BIRC6 MELK JAK1 BPTF KIDINS220 OSBPL8 OXSR1 COL5A1 EPS8L2 KIF23 SMCHD1 GEMIN5 TSFM GSR USP10 EEF1B2 EIF4A1 PDCD11 PRKCSH CDC42 CTSL HERC4 | 1.04e-08 | 1297 | 202 | 27 | 33545068 | |
| Pubmed | Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. | 1.64e-08 | 6 | 202 | 4 | 1716634 | |
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 1.64e-08 | 6 | 202 | 4 | 2328996 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 1.64e-08 | 6 | 202 | 4 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 1.64e-08 | 6 | 202 | 4 | 7859283 | |
| Pubmed | 1.64e-08 | 6 | 202 | 4 | 2002257 | ||
| Pubmed | 1.64e-08 | 6 | 202 | 4 | 2450406 | ||
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 1.64e-08 | 6 | 202 | 4 | 284003 | |
| Pubmed | 1.64e-08 | 6 | 202 | 4 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 1.64e-08 | 6 | 202 | 4 | 1021597 | |
| Pubmed | 2.61e-08 | 16 | 202 | 5 | 10842072 | ||
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 3.81e-08 | 7 | 202 | 4 | 2451911 | |
| Pubmed | 3.81e-08 | 7 | 202 | 4 | 6160178 | ||
| Pubmed | 3.81e-08 | 7 | 202 | 4 | 8666240 | ||
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 3.81e-08 | 7 | 202 | 4 | 1401878 | |
| Pubmed | 3.81e-08 | 7 | 202 | 4 | 7949740 | ||
| Pubmed | 3.81e-08 | 7 | 202 | 4 | 8604219 | ||
| Pubmed | 5.07e-08 | 18 | 202 | 5 | 2338144 | ||
| Pubmed | 7.59e-08 | 8 | 202 | 4 | 2040456 | ||
| Pubmed | 7.59e-08 | 8 | 202 | 4 | 2824476 | ||
| Pubmed | 7.59e-08 | 8 | 202 | 4 | 3038891 | ||
| Pubmed | 7.59e-08 | 8 | 202 | 4 | 8486361 | ||
| Pubmed | 1.36e-07 | 9 | 202 | 4 | 93520 | ||
| Pubmed | 1.53e-07 | 22 | 202 | 5 | 11696558 | ||
| Pubmed | 1.67e-07 | 103 | 202 | 8 | 10819331 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PSMD5 SUCLG1 BIRC6 POLR1B OXSR1 KIF5C DNAH8 CAPZA2 UBA2 CPS1 LSM12 EEF1B2 NAMPT WDHD1 USO1 EIF4A1 PDCD11 CDC42 | 1.85e-07 | 704 | 202 | 18 | 29955894 |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 32697825 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 1.93e-07 | 3 | 202 | 3 | 21827821 | |
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 1.93e-07 | 3 | 202 | 3 | 2436036 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 15299664 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 22063648 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 1.93e-07 | 3 | 202 | 3 | 7678001 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 1699843 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 1.93e-07 | 3 | 202 | 3 | 2413838 | |
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 1.93e-07 | 3 | 202 | 3 | 6360562 | |
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 1.93e-07 | 3 | 202 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 1.93e-07 | 3 | 202 | 3 | 17223109 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 8413315 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 6098446 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 30982860 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 12527308 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 2414282 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 28659346 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 25588701 | ||
| Pubmed | 2.26e-07 | 10 | 202 | 4 | 9121556 | ||
| Pubmed | 2.26e-07 | 10 | 202 | 4 | 2897103 | ||
| Pubmed | 3.53e-07 | 11 | 202 | 4 | 23449223 | ||
| Pubmed | 3.53e-07 | 11 | 202 | 4 | 1617215 | ||
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 3.53e-07 | 11 | 202 | 4 | 8589528 | |
| Pubmed | 3.53e-07 | 11 | 202 | 4 | 7608209 | ||
| Pubmed | 3.53e-07 | 11 | 202 | 4 | 2903254 | ||
| Pubmed | 3.53e-07 | 11 | 202 | 4 | 2565740 | ||
| Pubmed | Evolution of the mammalian G protein alpha subunit multigene family. | 4.05e-07 | 49 | 202 | 6 | 1302014 | |
| Pubmed | 5.27e-07 | 12 | 202 | 4 | 8144363 | ||
| Pubmed | 7.58e-07 | 13 | 202 | 4 | 489953 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 7.58e-07 | 13 | 202 | 4 | 7829080 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 2458567 | ||
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 7.69e-07 | 4 | 202 | 3 | 8543783 | |
| Pubmed | An amylase/Cre transgene marks the whole endoderm but the primordia of liver and ventral pancreas. | 7.69e-07 | 4 | 202 | 3 | 16786601 | |
| Interaction | CPNE5 interactions | 3.26e-06 | 42 | 198 | 6 | int:CPNE5 | |
| Cytoband | 1p21 | 6.23e-08 | 24 | 202 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 8.41e-06 | 107 | 202 | 6 | chr1p21 | |
| Cytoband | 1q42.2 | 1.80e-04 | 25 | 202 | 3 | 1q42.2 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.83e-06 | 161 | 141 | 9 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 2.08e-05 | 193 | 141 | 9 | 594 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.80e-04 | 3 | 141 | 2 | 297 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.17e-03 | 206 | 141 | 7 | 682 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 1.24e-03 | 7 | 141 | 2 | 917 | |
| GeneFamily | Schlafen family | 1.24e-03 | 7 | 141 | 2 | 1110 | |
| GeneFamily | Fibulins | 1.64e-03 | 8 | 141 | 2 | 556 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.61e-03 | 10 | 141 | 2 | 53 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.71e-03 | 40 | 141 | 3 | 321 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 3.79e-03 | 12 | 141 | 2 | 670 | |
| GeneFamily | Kelch like|BTB domain containing | 4.27e-03 | 42 | 141 | 3 | 617 | |
| Coexpression | LEE_AGING_MUSCLE_UP | 6.59e-07 | 41 | 200 | 6 | MM698 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SETX ATP8B1 MELK ITPR1 BPTF KIDINS220 ATXN2 TUBGCP3 OSBPL8 PHLPP1 OXSR1 KIF5C KIF23 SUPT20H CDC42BPA WNT5A SMCHD1 NAMPT AKAP9 WDHD1 CRYBG3 HERC4 | 7.25e-07 | 856 | 200 | 22 | M4500 |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | ITPR1 ITPR2 JAG1 SIPA1L2 VCAM1 KLHL6 COL5A1 FLT1 ATL1 HMCN1 GALNT11 ZNF721 ACSL5 | 8.14e-07 | 309 | 200 | 13 | M1973 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SETX VPS13C ITPR1 ITPR2 BPTF NUDT12 ZNF117 KIDINS220 JAG1 OSBPL8 OSBPL10 KIT KIF23 CDC42BPA SMCHD1 ZNF407 ATL1 WDHD1 | 3.19e-06 | 656 | 200 | 18 | M18979 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SETX DOCK11 RASSF2 VPS13C BIRC6 ITPR1 ITPR2 PCNX2 JAK1 BPTF KMT2C KIDINS220 GFOD1 PIK3R1 OSBPL8 KIT SMCHD1 UBA2 EPG5 HIVEP3 EEF1B2 CD5 AKAP9 VWA5A GZMH LPIN2 ZNF721 SLFN11 CDC42 | 3.46e-06 | 1492 | 200 | 29 | M40023 |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 6.51e-06 | 60 | 200 | 6 | MM654 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | NFASC CSMD3 PIK3R1 FGF9 KIF5C CACNA1C KLHL1 ANK2 DSCAM ARHGAP23 FAT3 HIVEP3 AKAP9 VWA5A LSAMP CDH4 | 1.17e-05 | 584 | 200 | 16 | M39068 |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_DN | TRIM34 KIT VCAM1 AMY1B AMY1C WIPI1 AMY2A AMY2B FRMPD2 HID1 CD28 | 2.24e-05 | 302 | 200 | 11 | MM1046 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | NFASC LRRTM3 CSMD3 EML5 GFOD1 RBMS3 PGAP1 FGF9 KIF5C CACNA1C KLHL1 ANK2 DSCAM ADAMTS5 AKAP9 LSAMP CDH4 | 3.05e-05 | 703 | 200 | 17 | M39070 |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 3.13e-05 | 116 | 200 | 7 | MM1240 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | CLSTN2 FGF9 KIF5C KLHL1 ANK2 DSCAM ARHGAP23 FAT3 HIVEP3 VWA5A LSAMP PLEKHM3 CDH4 ACSL5 | 3.74e-05 | 506 | 200 | 14 | M39067 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | NFASC LRRC2 CSMD3 GFOD1 RBMS3 PGAP1 FGF9 KIF5C HCFC2 CACNA1C ANK2 DSCAM ARHGAP23 NXPH1 ATL1 HIVEP3 AKAP9 VWA5A LSAMP SERINC5 FRMPD3 CDH4 | 4.11e-05 | 1106 | 200 | 22 | M39071 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | MKRN4P TET2 RASSF2 AXL DIPK1A MKRN1 NFASC ITPR2 KIDINS220 FBXO10 COL6A1 WIPI1 DSCAM ARHGAP23 PRICKLE1 DUSP7 ATL1 GALNT11 VWA5A LSAMP PLEKHM3 SERINC5 | 5.22e-05 | 1124 | 200 | 22 | MM1070 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | CCP110 DIPK1A ITPR1 PCNX2 CEP68 AMY1A AMY1B AMY1C AMY2A AMY2B AKAP9 VWA5A | 6.16e-05 | 399 | 200 | 12 | M41172 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MELK BPTF ATXN2 TUBGCP3 OSBPL8 PHLPP1 OXSR1 KIF5C KIF23 CDC42BPA WNT5A SMCHD1 AKAP9 | 6.54e-05 | 466 | 200 | 13 | M13522 |
| Coexpression | BERGER_MBD2_TARGETS | 6.90e-05 | 11 | 200 | 3 | MM905 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN | 7.32e-05 | 179 | 200 | 8 | M6689 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_ADDNL_EXON_LVL_UP | 8.54e-05 | 94 | 200 | 6 | M40880 | |
| Coexpression | GSE6259_CD4_TCELL_VS_CD8_TCELL_UP | 9.93e-05 | 187 | 200 | 8 | M6738 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TET2 RASSF2 AXL DIPK1A MKRN1 NFASC ITPR2 KIDINS220 FBXO10 COL6A1 WIPI1 DSCAM ARHGAP23 PRICKLE1 DUSP7 ATL1 GALNT11 VWA5A LSAMP PLEKHM3 SERINC5 | 1.13e-04 | 1102 | 200 | 21 | M2369 |
| Coexpression | ZHONG_PFC_C4_PTGDS_POS_OPC | 1.40e-04 | 147 | 200 | 7 | M39099 | |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_UP | CLSTN2 JAK1 PIK3R1 JAG1 KIT TRMT9B FAT3 DUSP7 HIVEP3 HMCN1 SLFN11 CDH4 | 1.45e-04 | 437 | 200 | 12 | M15981 |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN | 1.53e-04 | 199 | 200 | 8 | M7924 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN | 1.53e-04 | 199 | 200 | 8 | M5240 | |
| Coexpression | GSE22886_TH1_VS_TH2_48H_ACT_DN | 1.58e-04 | 200 | 200 | 8 | M4512 | |
| Coexpression | GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP | 1.58e-04 | 200 | 200 | 8 | M3413 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | MKRN4P MKRN1 ATP8B1 ARMCX1 JAK1 KMT2C OSBPL8 PHLPP1 FLT1 AMY1B AMY1C AMY2A AMY2B ADAMTS5 LPIN2 UBR3 ZNF721 SERINC5 | 1.68e-04 | 888 | 200 | 18 | MM1018 |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | AXL IFIT5 MELK ARMCX1 JAG1 PGAP1 DNAH8 CLEC12B ADCY4 ARHGAP23 PRICKLE1 ZSWIM5 WNT5A SMCHD1 NRIP3 SLFN13 LPIN2 RNF122 CTSL | 1.78e-04 | 973 | 200 | 19 | M41080 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | TET2 AXL LRRTM3 VNN1 JAG1 PGAP1 KLHL23 ELOVL6 KIT VCAM1 COL6A1 WNT5A FAT3 GRIN2A ADAMTS5 EEF1B2 HMCN1 SLFN13 SNX25 SERINC5 CTSL | 9.44e-06 | 773 | 195 | 21 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | DOCK11 CLSTN2 LRRTM3 ITPR2 RBMS3 BHMT2 OSBPL8 KIT ADAMTSL3 ATP10D HMCN1 P2RY1 LSAMP CRYBG3 | 1.55e-13 | 184 | 202 | 14 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NFASC RBMS3 PGAP1 CACNA1C COL5A1 COL6A1 ANK2 FAT3 ADAMTSL3 HMCN1 LSAMP | 1.30e-09 | 191 | 202 | 11 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NFASC RBMS3 PGAP1 CACNA1C COL5A1 COL6A1 ANK2 FAT3 ADAMTSL3 HMCN1 LSAMP | 1.37e-09 | 192 | 202 | 11 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | NFASC RBMS3 CACNA1C COL5A1 COL6A1 FAT3 ADAMTSL3 HIVEP3 HMCN1 LSAMP CDH4 | 1.45e-09 | 193 | 202 | 11 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | AXL NFASC CLSTN2 LRRTM3 ADCY5 HMCN2 JAG1 CACNA1C COL6A1 AIRE GRIN2A | 1.80e-09 | 197 | 202 | 11 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | NFASC RBMS3 CACNA1C COL5A1 COL6A1 ANK2 FAT3 ADAMTSL3 HMCN1 LSAMP | 1.75e-08 | 190 | 202 | 10 | 3a42a9b98d954685d38a741f44545898d0e3e9ce |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 2.24e-08 | 195 | 202 | 10 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NFASC RBMS3 CACNA1C COL5A1 COL6A1 ANK2 FAT3 ADAMTSL3 HMCN1 LSAMP | 2.36e-08 | 196 | 202 | 10 | 7d8505dac15fa59935ccf592afc54b04c4c6554f |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NFASC RBMS3 CACNA1C COL5A1 COL6A1 ANK2 FAT3 ADAMTSL3 HMCN1 LSAMP | 2.59e-08 | 198 | 202 | 10 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.65e-08 | 148 | 202 | 9 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | TET2 VPS13C GALNT7 BPTF PIK3R1 OSBPL8 KIT CDC42BPA AKAP9 LPIN2 | 2.72e-08 | 199 | 202 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NFASC RBMS3 CACNA1C COL5A1 COL6A1 ANK2 FAT3 ADAMTSL3 HMCN1 LSAMP | 2.85e-08 | 200 | 202 | 10 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | AXL NFASC CLSTN2 LRRTM3 ADCY5 HMCN2 JAG1 CACNA1C COL6A1 FAT3 | 2.85e-08 | 200 | 202 | 10 | a66449b22b39dd6987fc2c3ed160d24564234ced |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | DOCK11 CLSTN2 ADCY5 BHMT2 OSBPL10 SLC25A48 ANK2 GRIN2A SERINC5 | 1.57e-07 | 182 | 202 | 9 | eb138aa1dca9373f1586600f258df06dcf56d81f |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.89e-07 | 186 | 202 | 9 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.97e-07 | 187 | 202 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 1.97e-07 | 187 | 202 | 9 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-07 | 189 | 202 | 9 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-07 | 190 | 202 | 9 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | (2)_5-FU-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 2.26e-07 | 190 | 202 | 9 | 6b391b8a3ffcbdec3acaf242bc52fc3fc9da77c8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.26e-07 | 190 | 202 | 9 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-07 | 190 | 202 | 9 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.36e-07 | 191 | 202 | 9 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | AXL ATP8B1 ITPR1 RBMS3 KLHL23 COL5A1 COL6A1 ADAMTS5 ADAMTSL3 | 2.36e-07 | 191 | 202 | 9 | b7a57691a4742070cee640e285c1f4d0da95baf1 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-07 | 192 | 202 | 9 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.58e-07 | 193 | 202 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.69e-07 | 194 | 202 | 9 | 4199900d16623eca02d674d5ada7f0989e47955e | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.69e-07 | 194 | 202 | 9 | 4428b472c2042f88eae028b1770767512a515b75 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | CLSTN2 HMCN2 RBMS3 CACNA1C COL5A1 COL6A1 ANK2 ADAMTSL3 NAMPT | 2.81e-07 | 195 | 202 | 9 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | RBMS3 PIK3R1 CACNA1C COL5A1 COL6A1 FAT3 ADAMTSL3 HMCN1 LSAMP | 2.94e-07 | 196 | 202 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 3.20e-07 | 198 | 202 | 9 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-07 | 199 | 202 | 9 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CLSTN2 RBMS3 CACNA1C COL5A1 COL6A1 ANK2 ADAMTSL3 NAMPT LSAMP | 3.48e-07 | 200 | 202 | 9 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_CD56bright|COVID-19_Mild / Disease, condition lineage and cell class | 3.48e-07 | 200 | 202 | 9 | bb21e26a8b7cbceddb1ab5163a223a186d914da4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.48e-07 | 200 | 202 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 3.48e-07 | 200 | 202 | 9 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 202 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 3.48e-07 | 200 | 202 | 9 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 202 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 202 | 9 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 202 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 202 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.50e-07 | 158 | 202 | 8 | 2ae863ccef201414b82a2ecf7cf1bbb1b0ce4a3c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.82e-07 | 159 | 202 | 8 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 169 | 202 | 8 | f6a6d2f614d60395ad9b867ff1cf59eba72b04ce | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 169 | 202 | 8 | df2c9c706bfc9db2bc5726602a49f5f5a94e9481 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-06 | 121 | 202 | 7 | a5962d1c476e6966870832b72d511607e047248b | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.53e-06 | 177 | 202 | 8 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.66e-06 | 179 | 202 | 8 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-06 | 180 | 202 | 8 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-06 | 181 | 202 | 8 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 1.96e-06 | 183 | 202 | 8 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 1.96e-06 | 183 | 202 | 8 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.13e-06 | 185 | 202 | 8 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.13e-06 | 185 | 202 | 8 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 2.13e-06 | 185 | 202 | 8 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.30e-06 | 187 | 202 | 8 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.30e-06 | 187 | 202 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.30e-06 | 187 | 202 | 8 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.30e-06 | 187 | 202 | 8 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 188 | 202 | 8 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 188 | 202 | 8 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 188 | 202 | 8 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 188 | 202 | 8 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-06 | 132 | 202 | 7 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.49e-06 | 189 | 202 | 8 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.49e-06 | 189 | 202 | 8 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 189 | 202 | 8 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 2.59e-06 | 190 | 202 | 8 | ff083168d609957d00888f31b3488d6d56c902b4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-06 | 191 | 202 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-06 | 191 | 202 | 8 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | facs-Aorta-Heart-18m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 191 | 202 | 8 | 6242f83acaf1714e9c1771a832cb67674b19e96d | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.70e-06 | 191 | 202 | 8 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-06 | 191 | 202 | 8 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-06 | 191 | 202 | 8 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | COVID-19_Moderate-CD4+_Tcm|World / disease group, cell group and cell class | 2.80e-06 | 192 | 202 | 8 | 5f94310f1470487816fce697ffcdc2627fc66878 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.80e-06 | 192 | 202 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.80e-06 | 192 | 202 | 8 | e07b6892276c81c1227e94ca942f6820d89a7ca3 | |
| ToppCell | COVID-19_Severe-CD4+_Tcm|World / disease group, cell group and cell class | 2.80e-06 | 192 | 202 | 8 | 3352f13a6e706991dcf3ec173587bb6aba36a385 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.80e-06 | 192 | 202 | 8 | c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.80e-06 | 192 | 202 | 8 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.91e-06 | 193 | 202 | 8 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.91e-06 | 193 | 202 | 8 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.03e-06 | 194 | 202 | 8 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-06 | 194 | 202 | 8 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.03e-06 | 194 | 202 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 3.03e-06 | 194 | 202 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.03e-06 | 194 | 202 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-06 | 194 | 202 | 8 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 3.15e-06 | 195 | 202 | 8 | e8ab3122f81cb22920becd6611cbd9f00db19d50 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-06 | 195 | 202 | 8 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.15e-06 | 195 | 202 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.15e-06 | 195 | 202 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.27e-06 | 196 | 202 | 8 | 6eabbac1625f715531bae562a28da27664572600 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-06 | 197 | 202 | 8 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-06 | 197 | 202 | 8 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.52e-06 | 198 | 202 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.52e-06 | 198 | 202 | 8 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.65e-06 | 199 | 202 | 8 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.65e-06 | 199 | 202 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| Drug | R 623 | 2.82e-10 | 6 | 198 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 2.82e-10 | 6 | 198 | 5 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 2.82e-10 | 6 | 198 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 2.82e-10 | 6 | 198 | 5 | CID000127364 | |
| Drug | CNP-G3 | 2.82e-10 | 6 | 198 | 5 | CID003082910 | |
| Drug | AC1L5BOU | 9.79e-10 | 7 | 198 | 5 | CID000174858 | |
| Drug | BG5P | 9.79e-10 | 7 | 198 | 5 | CID003082752 | |
| Drug | desethylaprophen | 2.59e-09 | 8 | 198 | 5 | CID000163919 | |
| Drug | azintamide | 2.59e-09 | 8 | 198 | 5 | CID000071105 | |
| Drug | N-PMT | 5.55e-09 | 4 | 198 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 5.55e-09 | 4 | 198 | 4 | CID003482066 | |
| Drug | SAIB-SG | 5.55e-09 | 4 | 198 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 5.55e-09 | 4 | 198 | 4 | CID013573844 | |
| Drug | Dembrexine | 5.55e-09 | 4 | 198 | 4 | CID000072009 | |
| Drug | g lw | 5.55e-09 | 4 | 198 | 4 | CID000444139 | |
| Drug | beta-santalene | 5.55e-09 | 4 | 198 | 4 | CID000010534 | |
| Drug | alpha-maltosyl fluoride | 5.79e-09 | 9 | 198 | 5 | CID000194237 | |
| Drug | trestatin A | 5.79e-09 | 9 | 198 | 5 | CID003054994 | |
| Drug | AC1LAC07 | 1.15e-08 | 10 | 198 | 5 | CID000485275 | |
| Drug | Glc)4 | 1.15e-08 | 10 | 198 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 1.15e-08 | 10 | 198 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 1.15e-08 | 10 | 198 | 5 | CID000118008 | |
| Drug | validamycin D | 2.09e-08 | 11 | 198 | 5 | CID000166726 | |
| Drug | FG5P | 2.09e-08 | 11 | 198 | 5 | CID000127486 | |
| Drug | CNP-G5 | 2.09e-08 | 11 | 198 | 5 | CID000127309 | |
| Drug | HgI2 | 2.09e-08 | 11 | 198 | 5 | CID000024485 | |
| Drug | 2C KM | 2.09e-08 | 11 | 198 | 5 | CID009549196 | |
| Drug | Deposiston | 2.76e-08 | 5 | 198 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 2.76e-08 | 5 | 198 | 4 | CID010358258 | |
| Drug | lunularic acid | 2.76e-08 | 5 | 198 | 4 | CID000161413 | |
| Drug | himachalene | 2.76e-08 | 5 | 198 | 4 | CID000015095 | |
| Drug | actinidine | 2.76e-08 | 5 | 198 | 4 | CID000068231 | |
| Drug | 2TAA | 2.76e-08 | 5 | 198 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 2.76e-08 | 5 | 198 | 4 | CID006449879 | |
| Drug | silver perchlorate | 2.76e-08 | 5 | 198 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 2.76e-08 | 5 | 198 | 4 | CID000155287 | |
| Drug | azaprophen | 3.56e-08 | 12 | 198 | 5 | CID000129486 | |
| Drug | methyl 1'-epiacarviosin | 5.75e-08 | 13 | 198 | 5 | CID000197426 | |
| Drug | isoacarbose | 5.75e-08 | 13 | 198 | 5 | CID000449165 | |
| Drug | 2-amino-6-picoline | 8.21e-08 | 6 | 198 | 4 | CID000015765 | |
| Drug | phenol blue | 8.21e-08 | 6 | 198 | 4 | CID000075078 | |
| Drug | Gu-4 | 8.21e-08 | 6 | 198 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 8.21e-08 | 6 | 198 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 8.21e-08 | 6 | 198 | 4 | CID000092801 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 8.21e-08 | 6 | 198 | 4 | CID009577343 | |
| Drug | AC1OAGH8 | 8.21e-08 | 6 | 198 | 4 | CID006857368 | |
| Drug | vermella | 8.21e-08 | 6 | 198 | 4 | CID000203726 | |
| Drug | hymenin | 8.21e-08 | 6 | 198 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 8.21e-08 | 6 | 198 | 4 | CID000011615 | |
| Drug | Cyclodextrins | 8.88e-08 | 14 | 198 | 5 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 8.88e-08 | 14 | 198 | 5 | CID000012074 | |
| Drug | terephthaloyl chloride | 8.88e-08 | 14 | 198 | 5 | CID000007488 | |
| Drug | 4-nitrophenylmaltoheptaoside | 1.32e-07 | 15 | 198 | 5 | CID000173254 | |
| Drug | 2ai8 | 1.32e-07 | 15 | 198 | 5 | CID005289329 | |
| Drug | methyl blue | 1.90e-07 | 7 | 198 | 4 | CID011969534 | |
| Drug | 3KBG5CNP | 1.90e-07 | 7 | 198 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 1.90e-07 | 7 | 198 | 4 | CID000071762 | |
| Drug | Paramax | 1.90e-07 | 7 | 198 | 4 | CID000156411 | |
| Drug | amino-methyl | 1.90e-07 | 7 | 198 | 4 | CID000142005 | |
| Drug | gamma-cyclodextrin | 1.91e-07 | 16 | 198 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 1.91e-07 | 16 | 198 | 5 | CID003085308 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 2.00e-07 | 30 | 198 | 6 | CID005373003 | |
| Drug | R625 | 3.65e-07 | 33 | 198 | 6 | CID000072375 | |
| Drug | trimitan | 3.70e-07 | 18 | 198 | 5 | CID000005561 | |
| Drug | aprophen | 3.70e-07 | 18 | 198 | 5 | CID000071128 | |
| Drug | pentylamine | 3.72e-07 | 53 | 198 | 7 | CID000008060 | |
| Drug | boric acid gel | 3.78e-07 | 8 | 198 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 3.78e-07 | 8 | 198 | 4 | CID005317411 | |
| Drug | N-vinylcaprolactam | 3.78e-07 | 8 | 198 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 3.78e-07 | 8 | 198 | 4 | CID000146692 | |
| Drug | acrinor | 3.78e-07 | 8 | 198 | 4 | CID005489637 | |
| Drug | NSC300622 | 3.78e-07 | 8 | 198 | 4 | CID000028426 | |
| Drug | theodrenaline | 3.78e-07 | 8 | 198 | 4 | CID000071857 | |
| Drug | rhodanile blue | 3.78e-07 | 8 | 198 | 4 | CID000073372 | |
| Drug | trypanothione disulfide | 4.24e-07 | 140 | 198 | 10 | CID000115098 | |
| Drug | PNPC | 5.28e-07 | 35 | 198 | 6 | CID000165125 | |
| Drug | AC1N3UXZ | 6.48e-07 | 3 | 198 | 3 | CID004118625 | |
| Drug | GSAD | 6.76e-07 | 9 | 198 | 4 | CID009909127 | |
| Drug | GU-3 | 6.76e-07 | 9 | 198 | 4 | CID000448687 | |
| Drug | zingiberene | 6.76e-07 | 9 | 198 | 4 | CID000092776 | |
| Drug | Atonik | 6.76e-07 | 9 | 198 | 4 | CID000069471 | |
| Drug | H 187 | 6.76e-07 | 9 | 198 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 6.76e-07 | 9 | 198 | 4 | CID000024864 | |
| Drug | NRB02976 | 6.99e-07 | 58 | 198 | 7 | CID005354459 | |
| Drug | AC1L3XPY | 8.59e-07 | 21 | 198 | 5 | CID000124005 | |
| Drug | Dasatinib | EPHB4 RASSF2 MELK ITPR1 JAG1 FGF9 ELOVL6 KIT CACNA1C KIF23 ADAMTS5 WDHD1 HMCN1 SHCBP1 LSAMP SLFN11 HERC4 | 1.06e-06 | 478 | 198 | 17 | ctd:D000069439 |
| Drug | maltosaccharide | 1.10e-06 | 22 | 198 | 5 | CID005461034 | |
| Drug | I ZE | 1.12e-06 | 10 | 198 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 1.12e-06 | 10 | 198 | 4 | CID000012135 | |
| Drug | CG-120 | 1.12e-06 | 10 | 198 | 4 | CID000171403 | |
| Drug | eicosa-11,14-dienoic acid | 1.12e-06 | 10 | 198 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 1.12e-06 | 10 | 198 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 1.12e-06 | 10 | 198 | 4 | CID000440202 | |
| Drug | cycloprodigiosin | 1.40e-06 | 23 | 198 | 5 | CID006439795 | |
| Drug | Tempamine | 1.75e-06 | 11 | 198 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 1.75e-06 | 11 | 198 | 4 | CID000164608 | |
| Drug | AMO-1618 | 1.75e-06 | 11 | 198 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 1.75e-06 | 11 | 198 | 4 | CID000430710 | |
| Drug | Panose B | 1.76e-06 | 24 | 198 | 5 | CID000439297 | |
| Drug | CID439354 | 2.18e-06 | 25 | 198 | 5 | CID000439354 | |
| Disease | alpha-amylase 1 measurement | 2.27e-07 | 9 | 195 | 4 | EFO_0801371 | |
| Disease | Neurodevelopmental Disorders | 3.65e-05 | 93 | 195 | 6 | C1535926 | |
| Disease | serum gamma-glutamyl transferase measurement | DOCK11 AXL ATP8B1 CSMD3 ITPR1 BPTF GADD45G RBMS3 PIK3R1 SIPA1L2 ARHGAP21 CDC42BPA ZSWIM5 CAPZA2 ADAM30 CPS1 EYS MUC6 | 3.97e-05 | 914 | 195 | 18 | EFO_0004532 |
| Disease | Hypoxic Brain Damage | 4.35e-05 | 2 | 195 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 4.35e-05 | 2 | 195 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 4.35e-05 | 2 | 195 | 2 | C1527348 | |
| Disease | Anoxia of brain | 4.35e-05 | 2 | 195 | 2 | C0995195 | |
| Disease | Abnormality of refraction | RASSF2 PKD1L1 BIRC6 ADCY5 ITPR2 RBMS3 COL5A1 COL6A1 FLT1 DSCAM FAT3 FRMPD2 GRIN2A HIVEP3 CRYGN | 4.53e-05 | 673 | 195 | 15 | HP_0000539 |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 5.98e-05 | 12 | 195 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | platelet crit | TET2 DIPK1A ADCY5 ITPR2 JAK1 USP38 ATXN2 KLHL23 PHLPP1 POLR1B KIT CACNA1C CAPZA2 MFSD2B ZNF407 CPS1 EPG5 TBC1D10A | 6.68e-05 | 952 | 195 | 18 | EFO_0007985 |
| Disease | Colorectal Carcinoma | TET2 RASSF2 CLSTN2 CSMD3 KMT2C NCR1 DNAH8 ANK2 FRMPD2 GRIN2A ADAMTSL3 HIVEP3 NAMPT AKAP9 ACSL5 | 7.27e-05 | 702 | 195 | 15 | C0009402 |
| Disease | osteoarthritis (is_marker_for) | 8.25e-05 | 35 | 195 | 4 | DOID:8398 (is_marker_for) | |
| Disease | gastrointestinal system disease (is_implicated_in) | 1.30e-04 | 3 | 195 | 2 | DOID:77 (is_implicated_in) | |
| Disease | diet measurement, HOMA-B | 2.55e-04 | 19 | 195 | 3 | EFO_0004469, EFO_0008111 | |
| Disease | Familial intrahepatic cholestasis of pregnancy | 2.58e-04 | 4 | 195 | 2 | C3489728 | |
| Disease | Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease | 2.58e-04 | 4 | 195 | 2 | C1301365 | |
| Disease | cysteine-rich secretory protein LCCL domain-containing 2 measurement | 2.58e-04 | 4 | 195 | 2 | EFO_0801512 | |
| Disease | Hypermetropia, Myopia | 2.74e-04 | 189 | 195 | 7 | HP_0000540, HP_0000545 | |
| Disease | citrulline measurement | 2.98e-04 | 20 | 195 | 3 | EFO_0009777 | |
| Disease | body composition measurement | 3.12e-04 | 193 | 195 | 7 | EFO_0005106 | |
| Disease | birth weight | TET2 PSMD2 ATP8B1 ADCY5 ITPR2 ATXN2 PIK3R1 JAG1 ARHGAP21 FLT1 | 3.46e-04 | 399 | 195 | 10 | EFO_0004344 |
| Disease | preeclampsia, fetal genotype effect measurement | 4.29e-04 | 5 | 195 | 2 | EFO_0000668, EFO_0007959 | |
| Disease | YKL40 measurement, cerebrospinal fluid biomarker measurement | 4.29e-04 | 5 | 195 | 2 | EFO_0004869, EFO_0006794 | |
| Disease | Brugada Syndrome (disorder) | 5.19e-04 | 24 | 195 | 3 | C1142166 | |
| Disease | leiomyosarcoma (is_marker_for) | 6.40e-04 | 6 | 195 | 2 | DOID:1967 (is_marker_for) | |
| Disease | X-16570 measurement | 6.40e-04 | 6 | 195 | 2 | EFO_0800759 | |
| Disease | foot muscle strength measurement | 6.40e-04 | 6 | 195 | 2 | EFO_0009699 | |
| Disease | Hallux valgus | 6.75e-04 | 60 | 195 | 4 | HP_0001822 | |
| Disease | Sezary Syndrome | 7.40e-04 | 27 | 195 | 3 | C0036920 | |
| Disease | anterior thigh muscle fat infiltration measurement | 8.24e-04 | 28 | 195 | 3 | EFO_0020936 | |
| Disease | vascular cell adhesion protein 1 measurement | 8.93e-04 | 7 | 195 | 2 | EFO_0020846 | |
| Disease | N-palmitoylglycine measurement | 8.93e-04 | 7 | 195 | 2 | EFO_0800342 | |
| Disease | urate measurement, bone density | WDR64 ITPR1 ITPR2 KIDINS220 DNAH8 COL5A1 DSCAM NXPH1 ATL1 EYS USO1 CDH4 | 9.04e-04 | 619 | 195 | 12 | EFO_0003923, EFO_0004531 |
| Disease | Cholestasis of pregnancy | 1.19e-03 | 8 | 195 | 2 | C0268318 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.19e-03 | 8 | 195 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Polycythemia Vera | 1.19e-03 | 8 | 195 | 2 | C0032463 | |
| Disease | coffee consumption measurement | 1.37e-03 | 182 | 195 | 6 | EFO_0006781 | |
| Disease | 1-ribosyl-imidazoleacetate measurement | 1.52e-03 | 9 | 195 | 2 | EFO_0800034 | |
| Disease | CCL2 measurement | 1.53e-03 | 126 | 195 | 5 | EFO_0004749 | |
| Disease | posterior thigh muscle fat infiltration measurement | 1.59e-03 | 35 | 195 | 3 | EFO_0020934 | |
| Disease | shoulder impingement syndrome | 1.73e-03 | 36 | 195 | 3 | EFO_1001178 | |
| Disease | reticulocyte measurement | DIPK1A MKRN1 PSMD2 BIRC6 ATXN2 PIK3R1 JAG1 USP32 OXSR1 ARHGAP21 WIPI1 MFSD2B USP10 EEF1B2 LPIN2 PRKCSH | 1.77e-03 | 1053 | 195 | 16 | EFO_0010700 |
| Disease | birth weight, parental genotype effect measurement | 1.80e-03 | 192 | 195 | 6 | EFO_0004344, EFO_0005939 | |
| Disease | Anemia, Sickle Cell | 1.89e-03 | 10 | 195 | 2 | C0002895 | |
| Disease | Peripheral T-Cell Lymphoma | 1.89e-03 | 10 | 195 | 2 | C0079774 | |
| Disease | Reactive hypoglycemia | 1.89e-03 | 10 | 195 | 2 | C0271710 | |
| Disease | Fasting Hypoglycemia | 1.89e-03 | 10 | 195 | 2 | C0271708 | |
| Disease | Antihypertensive use measurement | 1.99e-03 | 265 | 195 | 7 | EFO_0009927 | |
| Disease | red blood cell density measurement | TET2 PSMD2 TRIM34 ATP8B1 ATXN2 RBMS3 PIK3R1 JAG1 CACNA1C CAPZA2 MFSD2B CPS1 TF HERC4 | 2.25e-03 | 880 | 195 | 14 | EFO_0007978 |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 2.30e-03 | 11 | 195 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Hypoglycemia | 2.30e-03 | 11 | 195 | 2 | C0020615 | |
| Disease | Enzymopathy | 2.30e-03 | 11 | 195 | 2 | C0520572 | |
| Disease | Hand-foot syndrome, response to fluoropyrimidines | 2.30e-03 | 11 | 195 | 2 | EFO_0010825, EFO_1001893 | |
| Disease | Animal Mammary Neoplasms | 2.58e-03 | 142 | 195 | 5 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 2.58e-03 | 142 | 195 | 5 | C1257925 | |
| Disease | colorectal cancer, endometrial neoplasm | 2.70e-03 | 42 | 195 | 3 | EFO_0004230, MONDO_0005575 | |
| Disease | diabetic angiopathy (is_marker_for) | 2.75e-03 | 12 | 195 | 2 | DOID:11713 (is_marker_for) | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 2.80e-03 | 88 | 195 | 4 | EFO_0803332 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 2.89e-03 | 43 | 195 | 3 | DOID:9261 (is_marker_for) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.05e-03 | 447 | 195 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | cognitive function measurement | GATB PSMD2 CLSTN2 ATP8B1 CSMD3 BIRC6 JAK1 GADD45G PHLPP1 ARHGAP21 CACNA1C COL5A1 DSCAM GRIN2A ADAMTSL3 PAXIP1 CDC42 CDH4 ACSL5 | 3.18e-03 | 1434 | 195 | 19 | EFO_0008354 |
| Disease | hematologic cancer (implicated_via_orthology) | 3.23e-03 | 13 | 195 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | Genetic chronic primary adrenal insufficiency | 3.23e-03 | 13 | 195 | 2 | Orphanet_101960 | |
| Disease | multiple sclerosis symptom measurement | 3.50e-03 | 46 | 195 | 3 | EFO_0803536 | |
| Disease | glucagon measurement | 3.66e-03 | 154 | 195 | 5 | EFO_0008463 | |
| Disease | Mammary Neoplasms, Experimental | 3.76e-03 | 155 | 195 | 5 | C0024668 | |
| Disease | biological sex | 4.38e-03 | 230 | 195 | 6 | PATO_0000047 | |
| Disease | central corneal thickness | 4.63e-03 | 309 | 195 | 7 | EFO_0005213 | |
| Disease | Carcinomatosis | 4.65e-03 | 163 | 195 | 5 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 4.65e-03 | 163 | 195 | 5 | C0205697 | |
| Disease | Undifferentiated carcinoma | 4.65e-03 | 163 | 195 | 5 | C0205698 | |
| Disease | Anaplastic carcinoma | 4.65e-03 | 163 | 195 | 5 | C0205696 | |
| Disease | eosinophil percentage of granulocytes | 4.76e-03 | 234 | 195 | 6 | EFO_0007996 | |
| Disease | Carcinoma | 4.77e-03 | 164 | 195 | 5 | C0007097 | |
| Disease | Romano-Ward Syndrome | 4.91e-03 | 16 | 195 | 2 | C0035828 | |
| Disease | Huntington's disease (biomarker_via_orthology) | 4.91e-03 | 16 | 195 | 2 | DOID:12858 (biomarker_via_orthology) | |
| Disease | hypertension (is_marker_for) | 5.22e-03 | 53 | 195 | 3 | DOID:10763 (is_marker_for) | |
| Disease | peripheral arterial disease | 5.50e-03 | 54 | 195 | 3 | EFO_0004265 | |
| Disease | Antibody Deficiency Syndrome | 5.54e-03 | 17 | 195 | 2 | C0003257 | |
| Disease | Uremia | 5.54e-03 | 17 | 195 | 2 | C0041948 | |
| Disease | factor VII activating protease measurement | 5.79e-03 | 55 | 195 | 3 | EFO_0009368 | |
| Disease | Dupuytren Contracture | 5.81e-03 | 108 | 195 | 4 | EFO_0004229 | |
| Disease | Ischemic stroke | 5.96e-03 | 324 | 195 | 7 | HP_0002140 | |
| Disease | corneal topography | 6.00e-03 | 109 | 195 | 4 | EFO_0004345 | |
| Disease | fibrinogen measurement | 6.00e-03 | 109 | 195 | 4 | EFO_0004623 | |
| Disease | estradiol measurement | 6.19e-03 | 110 | 195 | 4 | EFO_0004697 | |
| Disease | alpha synuclein measurement | 6.20e-03 | 18 | 195 | 2 | EFO_0009323 | |
| Disease | peritonsillar abscess | 6.20e-03 | 18 | 195 | 2 | EFO_0007429 | |
| Disease | multiple sclerosis | TET2 DIPK1A CLSTN2 ITPR1 JAK1 ATXN2 VCAM1 PRICKLE1 TSFM CD28 | 6.40e-03 | 594 | 195 | 10 | MONDO_0005301 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKKCQGAAVVTVQFE | 1591 | Q9HCE0 | |
| YPGSCVKKNIDGTIE | 1401 | Q99996 | |
| EYGEKITCRNFIGKQ | 1816 | Q96N23 | |
| ALSAKPGGQVKCQYI | 106 | Q9NR09 | |
| PGGQVKCQYISAVDK | 111 | Q9NR09 | |
| ECIYSIQVQAGKGIN | 1266 | Q7Z407 | |
| GEQGKESLVQCVKTF | 616 | Q76N32 | |
| LQVYSKTGFNCDGKL | 76 | P10747 | |
| KGGNYCDKTHVIVNQ | 2941 | Q68DQ2 | |
| SRCQIKVGYKQEGLK | 3016 | Q8IZF6 | |
| TGCDGIIGSKLQYDK | 706 | Q9UNA0 | |
| AQEGTYTCIAKNTKT | 286 | Q2WEN9 | |
| NVKGIYAVGDVCGKA | 366 | P00390 | |
| LVCKDVAQGILSYGN | 206 | P20718 | |
| LIEGNTIYANKGCGV | 636 | Q9UK96 | |
| KGELYGSEKLTQECV | 121 | P31371 | |
| IQLSKITENYDCGTK | 91 | Q9NUQ8 | |
| DKINGNCTGIKIYVS | 471 | P0DTE7 | |
| NCTGIKIYVSDDGKA | 476 | P0DTE7 | |
| DKINGNCTGIKIYVS | 471 | P0DTE8 | |
| NCTGIKIYVSDDGKA | 476 | P0DTE8 | |
| NSKCQGQLEVYLKDG | 41 | P06127 | |
| VKGKGQLCTYFLNTD | 1051 | Q8NFM4 | |
| VNGSLIYGVCAGKKQ | 161 | O75879 | |
| IYGVCAGKKQSQVIP | 166 | O75879 | |
| DKINGNCTGIKIYVS | 471 | P0DUB6 | |
| NCTGIKIYVSDDGKA | 476 | P0DUB6 | |
| YGEIELQKVTIGNCN | 126 | Q96K78 | |
| NTYQLECRGVVKVKG | 1231 | O95622 | |
| DKINGNCTGIKIYVS | 471 | P19961 | |
| NCTGIKIYVSDDGKA | 476 | P19961 | |
| QIVTELQTNYIGKGC | 296 | Q9H4D0 | |
| GVTDCVAEIQKNKPY | 441 | Q12830 | |
| EGNIKLYCKGADTVI | 611 | O43520 | |
| GDKQETAVNIAYACK | 921 | Q9P241 | |
| NKTFLCYVVEAQGKG | 66 | Q9Y235 | |
| IQQVFESGGSKKCIQ | 211 | O43918 | |
| AVETKKQLCPYAAVG | 241 | Q13434 | |
| KAILDKNTNQCKGYG | 91 | Q6XE24 | |
| QTSLVPCGQDKYISK | 6 | P50749 | |
| NIVKYKGICTEDGGN | 936 | P23458 | |
| GLGKVSYIGVCQSKF | 96 | Q56VL3 | |
| TEGKNVYTEIKCNSL | 1386 | Q14571 | |
| GATAVVQAAYCAPKK | 26 | O95747 | |
| QKGYTLKCQTQSDFG | 591 | Q14680 | |
| KVVEYLKGGIDINTC | 46 | Q01484 | |
| DKINGNCTGIKIYVS | 471 | P04746 | |
| NCTGIKIYVSDDGKA | 476 | P04746 | |
| VTFYGGDCQLTLNKK | 121 | Q6ZW49 | |
| GTYLNQKGECVRKAQ | 706 | Q6W4X9 | |
| GTGVRKNKTITCYDT | 191 | P47900 | |
| LLQNGAKVNCSDKYG | 156 | Q9ULH0 | |
| EGCVKDVSYQGGKSI | 746 | Q8NEZ4 | |
| ACVTLKNEVYISGGK | 371 | Q8WZ60 | |
| SGRDGYKKALNSQVC | 331 | Q9Y5Z7 | |
| YQVENCKGKEGSALS | 146 | Q3MHD2 | |
| KRSVGGCEKSVSLQY | 451 | Q9P2G4 | |
| GCEKSVSLQYKKNQI | 456 | Q9P2G4 | |
| SVKYGCGNSQNILTV | 2211 | Q5T1H1 | |
| KEKQVTICCQGNYGA | 41 | O76036 | |
| ESCVAIKTLKGGYTE | 641 | P54760 | |
| NGTVECKAYNDVGKT | 486 | P10721 | |
| EGKNVYTEIKCNSLL | 1396 | Q14643 | |
| SCKTIYGEKTGTQPQ | 471 | Q86UW9 | |
| YNSGVICENTCKEKG | 106 | P14314 | |
| KGLYSCKVSNVAGEA | 3106 | Q8NDA2 | |
| VGSKCEVQVKNGGIY | 276 | Q99700 | |
| TCEKYGLGSQNIIDL | 141 | Q8WX39 | |
| LGKYGALVICETSEQ | 231 | P43897 | |
| GYKTTGGKDEEVVQC | 121 | P05160 | |
| CIKGYDVIAQAQSGT | 66 | P60842 | |
| EIRSCYLKSGNQKEG | 711 | A6NKB5 | |
| VSGLLIGQCSSQKDY | 26 | Q5SWX8 | |
| SGSVNLKGAVKCRAY | 276 | Q5SWX8 | |
| GIDKQYSNCTTIDKQ | 636 | Q32MH5 | |
| QLEVCQKSLTGYLEK | 1561 | Q96JB1 | |
| SQKGGLVVLKACDYS | 501 | Q8NCW6 | |
| YGQLGLGTDCKKQTS | 166 | Q5GLZ8 | |
| NKIIGKDYCQVSGSK | 86 | Q86YZ3 | |
| KGIPQAVYCKNGFID | 56 | Q9BYS8 | |
| GYKAGVCKQAEEVVV | 441 | A6NFX1 | |
| TENCYKVEGKANLSR | 271 | Q96CW5 | |
| AVKYVECSALTQKGL | 151 | P60953 | |
| EVKHCVINKTATGYG | 666 | P27986 | |
| IGLSNGKAKVCNYSG | 521 | Q6ZWE6 | |
| KNCVNTIKVYGDGAA | 126 | Q8WXF5 | |
| LKKVCGEEGVRVYSQ | 666 | Q9H6S3 | |
| LVNYGKVCNNSKKGL | 281 | Q13216 | |
| KVSDGGEYTCIAINQ | 3026 | Q96RW7 | |
| ELGGTVNITCQKTGY | 586 | Q9BZF1 | |
| IAKVKYGECGQGFSV | 521 | Q9NQV7 | |
| KQGQIYCSKTCSLGE | 296 | Q96MT3 | |
| QGIYTCVATNILGKA | 496 | O94856 | |
| YECQAVSSLGVKKVS | 486 | A1KZ92 | |
| TKGLKQSVCDQGFYN | 91 | Q9H5J4 | |
| GYVLKRCGNKIVEDN | 396 | Q9UKF2 | |
| VYGKGNPTKVVAVDC | 211 | P31327 | |
| QTDIYGLAKKCNLTE | 96 | Q8IU89 | |
| EEAQKYTGKIGNVCK | 111 | Q13325 | |
| NKLYLVGGQTTITEC | 466 | Q8NBE8 | |
| NGNKITCRGLVEYFK | 316 | Q8WXF7 | |
| DALVAGGICQTSIYK | 106 | Q9H2M3 | |
| YIQDLCGEKQTIGAL | 356 | Q9BVC3 | |
| CGEKQTIGALLTKYS | 361 | Q9BVC3 | |
| IGVQLFKGKLYTCSD | 1066 | Q13936 | |
| EAPYTLSGKKQGCIE | 1866 | Q5JSL3 | |
| GTYTDCAIKKGLEQL | 126 | P12109 | |
| QVGSQCSYLVAGTEK | 181 | A0A1W2PPK0 | |
| GICAKGVIVYEVKNN | 566 | Q68DX3 | |
| SCGTKGSAIQAKLQY | 371 | Q5JV73 | |
| QGCLTAGVYESAKVL | 36 | O95257 | |
| QYDQCLTKGADGSKV | 581 | Q86SF2 | |
| GSPQKCSALKAVYIG | 351 | Q8TDW7 | |
| QVKFSSCVGTKGTQY | 56 | P55283 | |
| CAKDSTNLDVLGKYG | 256 | Q16829 | |
| GLYKQAIVGDINIAC | 31 | Q8N6N7 | |
| GEVCIKGTNVFKGYL | 491 | Q9ULC5 | |
| VDGCATKKGYQKTVL | 1786 | P20908 | |
| DLAGVCSSKVYVGKN | 431 | O43303 | |
| GVAQRYKKVGECLGS | 436 | Q05BV3 | |
| GVPVSLKECFTYKGQ | 136 | O00519 | |
| LKECFTYKGQDSTLG | 141 | O00519 | |
| GYGIKKLQIQCVVED | 181 | P24534 | |
| KYKTGVIDGPACNSL | 66 | Q5T7M9 | |
| QKLVNMGGYTGKVCV | 496 | Q68D06 | |
| VYIVLCGDNGLSETK | 1816 | Q8TDX9 | |
| KVCLKEYQSRVTAGG | 76 | P78504 | |
| KGSQTNLKDPVGVYC | 16 | Q02241 | |
| AVETKKQLCPYAAVG | 206 | Q9UHC7 | |
| QRPKKTITYGGCVAQ | 86 | Q8NGZ4 | |
| LGYICKKGNTTLNSF | 336 | P22897 | |
| GKDVKALVDTGCLYN | 116 | Q9NQ35 | |
| GNSPITGYDIECKNK | 911 | O60469 | |
| EINGCISTGKEANVY | 181 | Q9BRS2 | |
| QIGSAKAKELAYTVC | 336 | Q9UGM6 | |
| CFLYKNQKGQGEIVS | 391 | O60763 | |
| GLQNKCKYGVFEESL | 401 | Q9BYJ4 | |
| SGIYVCEGVNLIGKN | 286 | P19320 | |
| KVIPNKVGTYCIQFG | 1451 | A6NHR9 | |
| CEVQVHGGSLLGKKY | 146 | Q9NXC2 | |
| CAKQIVKDVLEGYNG | 66 | O60282 | |
| VIDAVKNYSICGKST | 351 | Q86VH5 | |
| GITREQSGKYECKAA | 186 | Q13449 | |
| VYLVTCANLTNGGKS | 16 | P58417 | |
| YKEIQQCLVGNKGIE | 356 | Q9H3E2 | |
| DVCAYAGSGNVLKVQ | 596 | Q13200 | |
| QGCAIAKQLGAEIYL | 151 | Q92730 | |
| YKAVEKLVQGAESGC | 71 | Q8IV36 | |
| GNDKGISKVVYRSCN | 186 | Q8NE22 | |
| QHKIGILYCKAGQST | 606 | Q9P2F8 | |
| QGCTDYVSEVVKKGA | 1121 | Q7Z333 | |
| QKLVNMGGYTGKVCV | 496 | Q7Z7L1 | |
| GQVTTIKKGVTECYE | 146 | Q9UBT2 | |
| CSYVVTNGLGINVFK | 401 | P43490 | |
| TCGNATKIEEGGYKR | 286 | Q9BQG2 | |
| YGGSLQKQTKFVHEC | 136 | Q75T13 | |
| GVLDCISQSYQKEGL | 256 | Q6ZT89 | |
| CTGADIKISGIKFVQ | 426 | Q8NEM2 | |
| KSSGEIVYCGQVFEK | 56 | Q02543 | |
| YKLSETKGCQTVTSG | 1306 | Q5VT25 | |
| ELGGKVSINCAKTGY | 606 | Q9BXB5 | |
| YVDKNTKIICQGFTG | 51 | P53597 | |
| REKGYVTPVKNQGQC | 121 | P07711 | |
| CTVYGKKIDGQQTII | 141 | P47755 | |
| QGKIKTYISQVCDDT | 281 | Q9P291 | |
| KELDQINGSKGCAYF | 231 | Q2HXU8 | |
| GIYFVGLQKCFIKTQ | 111 | Q9H2S6 | |
| GQYLNCIVEKVKGNG | 236 | Q14690 | |
| SLKYNCTGLNFGKVD | 181 | Q9Y320 | |
| KSINECKVQKGGYNR | 116 | Q3SXZ3 | |
| VKEQVKLFLSQGGYC | 341 | Q9P217 | |
| NSIYVVANIGDKKPC | 131 | O95497 | |
| KLTGVAGNYTVCQKD | 346 | O95497 | |
| GEEYVKAVGNLRKCS | 671 | P02787 | |
| GDAKKLQLYGQTCAV | 81 | Q9H9V4 | |
| LGAQVPDAKKACTYI | 61 | P04844 | |
| INVGEKAYSCALKSG | 51 | O75717 | |
| VKVNGESVIGKTYSQ | 121 | Q9P227 | |
| VCKVQKGVYNGINKC | 46 | Q8TF20 | |
| KGVYNGINKCLSNTQ | 51 | Q8TF20 | |
| IKAGDTCEKLVGYSA | 76 | Q86VE9 | |
| GQHYDLKISKAGNCV | 276 | Q8NEM7 | |
| VTKGCYLATGSKDQT | 236 | Q8TEQ6 | |
| LKTKGVIYECNICGA | 636 | Q5T1R4 | |
| VCVADFGLSKKIYNG | 686 | P30530 | |
| ETTGEVCLKYTLQGK | 511 | O00534 | |
| DSANQGCVRKVYLKD | 3701 | Q709C8 | |
| QYIGEGAKTGIKECQ | 91 | P41221 | |
| ETGKTGLINLGNTCY | 441 | Q8NB14 | |
| GGEVQTSKKSYVCPN | 396 | Q96IT1 | |
| YKDLTSGLGENACVK | 276 | Q6ZT12 | |
| SVDECKVQKGGYNGL | 116 | Q96N22 | |
| IGCGTGKYLKVNSQV | 51 | Q9P272 | |
| GKYLKVNSQVHTVGC | 56 | Q9P272 | |
| YEKTGGCQKLIKNIE | 691 | Q14694 | |
| CKGNEYGKIISDGSN | 226 | Q86WZ6 | |
| VVECKQHKGDYSGLN | 56 | Q03924 | |
| HGYTEASGVKNKLCV | 1176 | O60346 | |
| VYCIGGENLSVAKAA | 131 | Q16401 | |
| GEGKIYECNQVQKFI | 126 | Q5HY98 | |
| IVSKSYECRLKGQGA | 1811 | Q9C0G0 | |
| GEIVLYDGNSLKTVC | 166 | Q5MNZ9 | |
| GATTNYGKDIVKACS | 266 | O96006 | |
| VQKGGISIINCAYEN | 41 | A0A075B6W5 | |
| EEGCSTQKQVLNYLG | 291 | Q9H9Y6 | |
| EGVYHCKATNQKGSV | 726 | P17948 | |
| SECGKAFGQKYLLVQ | 206 | Q96HQ0 | |
| KVNGESVIGKTYSQV | 126 | Q5T5U3 | |
| GSPEKVKACQGQYET | 316 | Q9BXI6 | |
| ESRGYSKCLQNGGIK | 81 | Q6N021 | |
| YTGLKKQLSDLCGLN | 946 | Q8NFA0 | |
| YCVKANVIVTGGDDK | 331 | B1ANS9 | |
| EVHKGGYNEVKQCLS | 136 | A0A1W2PQL4 | |
| NEGTYVCIATNALGK | 1361 | P82987 | |
| GLKTLNTVECYNPKT | 516 | Q9NR64 | |
| KELYKGINQATLSGC | 16 | Q92539 | |
| NYKAGRDEGCKLVTI | 736 | Q12879 |